Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Contineum Therapeutics, Inc.(CTNM) | 0 | 918,163 | +918,163 | 0 | 16,169 | 20.92% | +16,169 |
| Aligos Therapeutics, Inc. | 2,320,381 | 1,457,937 | -862,444 | 2,274 | 510 | 0.66% | -1,764 |
| Passage Bio, Inc.(PASG) | 4,959,769 | 4,026,417 | -933,352 | 6,696 | 3,198 | 4.14% | -3,498 |
| Adverum Biotechnologies, Inc. | 506,822 | 506,821 | -1 | 7,166 | 3,477 | 4.50% | -3,690 |
| Repare Therapeutics, Inc. | 2,646,657 | 2,646,657 | 0 | 12,466 | 8,734 | 11.30% | -3,732 |
| Gritstone Oncology, Inc. | 3,561,150 | 3,561,150 | 0 | 9,152 | 2,200 | 2.85% | -6,952 |
| CRISPR Therapeutics AG(CRSP) | 498,558 | 498,558 | 0 | 33,982 | 26,927 | 34.84% | -7,055 |
| Skye Bioscience, Inc.(SKYE) | 2,007,702 | 2,007,704 | +2 | 31,400 | 16,082 | 20.81% | -15,319 |